Thursday, August 29, 2013

US FDA probes brain infection in patient on Novartis's MS drug

(Reuters) - The U.S. Food and Drug Administration said it was investigating a case of a rare and serious brain infection that developed in a patient in Europe, who was being treated with Novartis's multiple sclerosis drug, Gilenya.

No comments:

Post a Comment

Subscribe Now: Feed Icon